1. Variations and natural history of primary intraparenchymal lesions associated with neurofibromatosis type 2
- Author
-
Shigeru Yamaguchi, Isao Yokota, Taisuke Harada, Michinari Okamoto, Hiroyuki Kameda, Kohsuke Kudo, Yukitomo Ishi, Shunsuke Terasaka, Miki Fujimura, Ryosuke Sawaya, Hiromi Okada, and Hiroaki Motegi
- Subjects
medicine.medical_specialty ,Neurology ,business.industry ,Cortical dysplasia ,medicine.disease ,Lesion ,Meningioma ,medicine ,Radiology, Nuclear Medicine and imaging ,Neurology (clinical) ,Neurosurgery ,Radiology ,medicine.symptom ,Neurofibromatosis type 2 ,Cardiology and Cardiovascular Medicine ,business ,Pathological ,Neuroradiology - Abstract
The study aimed to investigate the clinical implications and natural history of primary intraparenchymal lesions in patients with neurofibromatosis type 2. Radiological findings of 15 neurofibromatosis type 2 cases were retrospectively collected. Twenty-seven primary intraparenchymal lesions were observed in 7 out of 15 patients (47%). Cortical/subcortical T2 hyperintense lesions and enlarged Virchow–Robin spaces were the most common findings in five and four patients, respectively. During the follow-up period (median 84 months), one new primary intraparenchymal lesion was identified and increased lesions were observed in two cases on contrast-enhanced MRI. Surgical resection was performed in one case pathologically diagnosed with atypical meningioma. Twenty-five other lesions without contrast enhancement presented no apparent growth during follow-up. Although most primary intraparenchymal lesions are benign, a subset of cases would present newly developed or increased lesions on contrast-enhanced MRI. Careful monitoring is necessary for such cases, and pathological confirmation should be considered.
- Published
- 2021
- Full Text
- View/download PDF